New Research Question: Working to Improve Clinical Trial Design

There is an urgent need to make advances in clinical trial design in order to tackle critical problems in PD like modifying disease progression and levadopa-induced dyskinesia.  Join you colleagues in a discussion of the strengths and weaknesses of novel and traditional approaches to clinical trial design.  Dr. Laurence Negre-Pages, Dr. Olivier Rascol and their colleagues have posted an analysis of the strengths and limitations of the N-of-1 design.